Open AccessEfficacy of Mastodinone® for mastalgia correction in pre- and perimenopausal women
Author(s) -
Rozhkova Ni,
И. И. Бурдина,
С. Б. Запирова,
М. Л. Мазо,
Сергей Павлович Прокопенко,
О. Э. Якобс
Publication year - 2021
Publication title -
reproductive health of woman
Language(s) - English
Resource type - Journals
eISSN - 2708-8731
pISSN - 2708-8723
DOI - 10.30841/2708-8731.2.2021.232553
Subject(s) - tolerability , medicine , breast pain , quality of life (healthcare) , physical therapy , drug , drug treatment , gynecology , psychiatry , adverse effect , breast cancer , nursing , cancer
The purpose of the study wasto examine the effectiveness of the drug Mastodynon® for the treatment of mastopathy in pre- and perimenopausal women.Materials and methods. The research was carried out within 12 months. Patient presenting complaints of pain in the breast, passed a comprehensive examination (clinical and Х-ray and/or sonographic) and questionnaires at the first visit and every 6 months. The plant-based drug Mastodynon®.Results. We examined 38 patients aged 45–56 years. Most women in this group for many years were observed due to mastopathy of different forms and degrees of severity. After 6 months after start of treatment with Mastodynon® the majority of patients reported decrease or absence of pain in the breasts, improvement of psycho-emotional condition. The positive effect of various degree was observed in 71,05% of the patients. After 1 year revealed a stabilization of the therapeutic effect of the drug Mastodynon® in 83,3% of cases. Mastodynon® has shown high effectiveness, good tolerability in the treatment of mastopathy in women of pre- and perimenopausal age, it has improved thepatients quality of life.